Company Overview of Edimer Pharmaceuticals Inc.
Edimer Pharmaceuticals Inc. develops and delivers solutions for the improvement in the health and quality of life to future generations living with X-linked hypohidrotic ectodermal dysplasia (XLHED). It offers EDI200, an ectodysplasin A replacement protein for the treatment of XLHED. The company was founded in 2009 and is based in Cambridge, Massachusetts.
Cambridge, MA 02142
Founded in 2009
Key Executives for Edimer Pharmaceuticals Inc.
Edimer Pharmaceuticals Inc. Key Developments
Similar Private Companies By Industry
|Latona Life Sciences Inc.||United States|
|Raritan Pharmaceuticals Inc.||United States|
|Paxis Pharmaceuticals Inc.||United States|
|The Chemins Company, Inc.||United States|
|AnaptysBio, Inc.||United States|
Recent Private Companies Transactions
July 23, 2013
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Germany, PA | Life TechnologiesPosted: Nov 22
- Spring House, PA | Johnson & JohnsonPosted: Dec 05
- Palm Harbor, FL | HCA Physician ServicesPosted: Dec 04
- Puerto Rico | AbbviePosted: Dec 04
Sponsored Financial Commentaries
To contact Edimer Pharmaceuticals Inc., please visit www.edimerpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.